Grants

  • "Mechanisms of Viral Induced Demyelination", Teacher Investigator Award, National Institutes of Health - NS00849. Principal Investigator (12/83-11/88).
  • "Development of a Spinal Animal Model of Meningeal Carcinomatosis", Fraternal Order of Eagles National Cancer Fund. Co-Principal Investigator with Dr. G. Powis (4/84-4/85).
  • "Molecular Characterization of B-Lymphocyte Abnormalities in Ataxia-Telangiectasia Model", Fraternal Order of Eagles National Cancer Fund. Co-Principal Investigator with Dr. G. E. Woloschak (4/86-4/87).
  • "Tumor Immunology and Immunoregulation", National Institutes of Health Training Grant, CA09127-12. Co-Investigator (C. S. David, Program Director), (7/86-7/95).
  • "Immune Promotion of Remyelination", National Multiple Sclerosis Society, RG 1878-A-1. Principal Investigator (10/86-10/89).
  • "Searle Scholars Award" - Chicago Community Trust. Principal Investigator (9/86-9/90).
  • "Multiple Sclerosis in Olmsted County, 1950-1984: A population based investigation of the possible association with diabetes mellitus, autoimmune diseases, neoplastic disorders and head trauma" Project 2 - NS17750-P2. Principal Investigator – Rochester Neuroepidemiology Program Project, National Institutes of Health. (L. T. Kurland, Director) (12/81-6/92).
  • "Immune Promotion of Remyelination", National Institutes of Health, RO1- NS24180. Principal Investigator (9/87-9/95).
  • "Theiler's Virus-induced Demyelination and Remyelination", National Multiple Sclerosis Society, RG-1878-B-2. Principal Investigator (9/89-4/93).
  • "Immunopathology of Demyelination", National Multiple Sclerosis Society, RG 2174-A-3. Principal Investigator (4/90-9/93).
  • "Promotion of CNS Remyelination by Immunoglobulin in Myelin Deficient-Mutant Mice", The Myelin Project, Myelin Project #1. Principal Investigator (4/92-9/95).
  • "Development of an Animal Model for Multifocal Inflammatory Demyelination Induced by 5-Fluorouracil and Levamisole" - Mayo Foundation. Co-Principal Investigator with Dr. David W. Kimmel (6/92-6/93).
  • "Disability in Multiple Sclerosis: A Population-based Study in Olmsted County" – Mayo Foundation, MS #1. Principal Investigator (9/92-9/93).
  • "Fellowship in Neuroscience", Applebaum Family Support Foundation, Principal Investigator (6/93-Present).
  • "Intravenous Immunoglobulin Therapy in Multiple Sclerosis", Co-investigator. J. Noseworthy, Principal Investigator. National Multiple Sclerosis Society, RG 2520-A-1 (4/1/93-3/31/94).
  • "Novel Strategies to Promote Remyelination in the Central Nervous System", Peterson Grant #1, Principal Investigator (1/1/93-12/31/95).
  • "Disability and Rehabilitation Utilization Patterns in Multiple Sclerosis: A Population-based Study in Olmsted County, Minnesota", National Multiple Sclerosis Society, MS #2, Principal Investigator (7/93-7/94).
  • "Growth of Human Oligodendrocyte Progenitors In Vitro", Mayo Foundation, Co-principal Investigator with S. Hunter (1/94-12/97).
  • "Patterns of Health Care Service Utilization by Multiple Sclerosis Patients in Olmsted County, MN: A Population-Based Study", Co-principal Investigator with K. Stolp-Smith. National Multiple Sclerosis Society, MS #3, (1/94-12/95).
  • "Isolation and Characterization of MHC-bound Self Peptides in Autoimmune Disease", National Institutes of Health, NIH-NO1-AI-4-5197-02, Co-investigator with Dr. Peter Wettstein (3/94-2/99).
  • "Theiler's Murine Encephalomyelitis Virus Induced Demyelination in Normal and Mutant Mice", Multiple Sclerosis Society of Canada. Co-investigator with Dr. Tak W. Mak of the Ontario Cancer Institute/Princess Margaret Hospital (4/93-3/95).
  • "Intravenous Immunoglobulin in Multiple Sclerosis: Advanced MRI Studies", Myelin Project. Co-principal Investigator with Dr. John Noseworthy (3/94-3/95).
  • "Intravenous Immunoglobulin in Multiple Sclerosis". Co-investigator with Dr. John Noseworthy, National Institutes of Health, R01-NS-31506-01-A1 (4/94-3/98).
  • "T Cell Function in a Murine Model of Multiple Sclerosis", National Institutes of Health,R01 NS32129. Principal Investigator (8/94-7/99).
  • "Intravenous Immunoglobulin Therapy in Optic Neuritis", National Institutes of Health, R01 - U10EY10963-01. Co-Principal Investigator with Dr. John Noseworthy (4/95-3/98).
  • "Immune Promotion of Remyelination", National Multiple Sclerosis Society. Principal Investigator (10/95-9/98).
  • "Immune Promotion of Remyelinaton", National Institutes of Health, R01 NS24180. Principal Investigator (10/87-10/09).
  • "Promotion of Remyelination in Spinal Cord Injury", American Paralysis Association, #RA2-9503. Principal Investigator (1/1/96-12/31/97).
  • "Pre-Clinical Studies of a Monoclonal Antibody Designed to Promote Central Nervous System Repair", Acorda Therapeutics, Inc. Principal Investigator (10/1/95-9/30/98).
  • "Molecular Characterization of Antibody-Induced Remyelination", Acorda Therapeutics. (4/98-3/01).
  • "Plasma Exchange in Severe Demyelinating Disease", National Institutes of Health, R01 NS32774. Co-investigator with Dr. Brian Weinshenker (6/97-6/99).
  • "Myelin Repair in Multiple Sclerosis" Applebaum Foundation, Principal Investigator (6/97-6/01).
  • "T Cell Function in a Murine Model of Multiple Sclerosis" National Institute of Health, R01 NS32129. Principal Investigator (8/99 - 12/09).
  • "Optimization of Antibody Enhanced Remyelination", National Multiple Sclerosis Society, RG 3172-A-6. Principal Investigator (04/00-03/08).
  • "Immunogenetics of Demyelination" - Program Project Director, National Institutes of Health, P01-NS38468. "Effect of Transgenic Expression of Theiler's Virus Coding Region on Pathogenesis" - Principal Investigator, Project 1 of "Immunogenetics of Demyelination" Program Project (07/00-06/05).
  • "Human Monoclonal Antibodies for CNS Remyelination", National Institutes of Health, R41 NS40172-01. Principal Investigator (12/01/00-11/30/02).
  • "Human Antibodies to Promote CNS Regeneration", National Institutes of Health, R43 NS40209-01. Co-Investigator with Dr. Timothy Neuberger from Acorda Therapeutics (12/01/00-11/30/02).
  • "Remyelination in Multiple Sclerosis: Neural Precursor-Based Repair", MS Research Foundation of Canada. Principal Investigator, Project 4 under the supervision of Dr. Jack Antel (10/01-10/04).
  • "Human Monoclonal Antibodies for CNS Remyelination", Phase II STTR grant from National Institutes of Health, Allan Bieber - Principal Investigator with Acorda Pharmaceuticals (9/02-9/05).
  • "Mayo MSTP M.D./Ph.D. Program", National Institutes of Health, T32GM65841-01. Principal Investigator (7/03-7/07).
  • National Multiple Sclerosis Society Collaborative Research Center Grant (4/04-4/09), Moses Rodriguez, Principal Investigator.
  • "Genetic Analyses of Spontaneous Remyelination", National Multiple Sclerosis Society (10/03-9/05), Allan Bieber, Principal Investigator; Moses Rodriguez, Co-investigator.
  • "Measles Viruses with Added Vaccines". National Institutes of Health, R01-A157761. Dr. Cattaneo, Principal Investigator; Moses Rodriguez, Co-investigator.
  • "A Recombinant Human Monoclonal Antibody for Promoting Myelin Repair in Multiple Sclerosis". Conrad Hilton Foundation, 11/04-11/07. Principal Investigator, Moses Rodriguez.
  • "Mechanism of Axonal Loss in Multiple Sclerosis". Donald and Frances Herdrich Foundation, 11/04-11/09. Principal Investigator, Moses Rodriguez.
  • "Remyelination in Multiple Sclerosis: Neural Precursor- Based Repair." Canadian Multiple Sclerois Society. 7/05-6/08. Principal Investigator, Moses Rodriguez.
  • "Mayo Pediatric MS Center of Excellence," National Multiple Sclerosis Society (01/06 – 12/09), Nancy Kuntz, Principal Investigator; Moses Rodriguez, Co-investigator.
  • "Aspirin for the treatment of MS related fatigue," National Multiple Sclerosis Society, RG 3808-A1 (10/06 – 10/09), Dean Wingerchuk, Principal Investigator; Moses Rodriguez, Co-investigator.
  • "Non-Ambulatory Impairment in Benign Multiple Sclerosis," National Multiple Sclerosis Society (01/07-12/10), Orhun Kantarci, Principal Investigator; Moses Rodriguez, Co-investigator.